Morgan Stanley’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-156,238
| Closed | -$1.57M | – | 8071 |
|
|
2023
Q4 | $1.57M | Buy |
156,238
+57,590
| +58% | +$578K | ﹤0.01% | 5071 |
|
|
2023
Q3 | $284K | Buy |
98,648
+74,275
| +305% | +$214K | ﹤0.01% | 5427 |
|
|
2023
Q2 | $92.9K | Sell |
24,373
-471
| -2% | -$1.8K | ﹤0.01% | 5989 |
|
|
2023
Q1 | $46.2K | Buy |
24,844
+2,549
| +11% | +$4.74K | ﹤0.01% | 6319 |
|
|
2022
Q4 | $51.3K | Sell |
22,295
-196,813
| -90% | -$453K | ﹤0.01% | 6281 |
|
|
2022
Q3 | $705K | Sell |
219,108
-329,927
| -60% | -$1.06M | ﹤0.01% | 5089 |
|
|
2022
Q2 | $3.02M | Sell |
549,035
-78,758
| -13% | -$433K | ﹤0.01% | 4204 |
|
|
2022
Q1 | $1.46M | Buy |
627,793
+21,662
| +4% | +$50.5K | ﹤0.01% | 4737 |
|
|
2021
Q4 | $3.66M | Sell |
606,131
-357,204
| -37% | -$2.16M | ﹤0.01% | 4051 |
|
|
2021
Q3 | $13.4M | Sell |
963,335
-68,420
| -7% | -$949K | ﹤0.01% | 2563 |
|
|
2021
Q2 | $13.4M | Buy |
1,031,755
+110,725
| +12% | +$1.44M | ﹤0.01% | 2627 |
|
|
2021
Q1 | $14.2M | Buy |
+921,030
| New | +$14.2M | ﹤0.01% | 2283 |
|